منابع مشابه
Aromatase Inhibitors: a New Hope for Breast Cancer Patients
Breast Cancer is the leading cause of mortality among the women of age 30 to 60. Endocrine therapy used for the treatment has shown promising results in which the antiestrogen tamoxifen has been the standard first-line treatment used for more than 30 years. But its side effects like resistance, increase risk of thromboembolism, endometrial cancer and uterine sarcoma limits its use. The developm...
متن کاملPertuzumab: new hope for patients with HER2-positive breast cancer.
BACKGROUND Human epidermal growth factor receptor 2 (HER2) overexpression is detected in approximately 15% to 20% of all breast cancers (BCs). A revolutionary change in the prognosis of this subgroup of patients has occurred since trastuzumab therapy was introduced into daily clinical practice. However, because trastuzumab resistance is common, new molecules with complementary and/or synergisti...
متن کاملCannabinoids: a new hope for breast cancer therapy?
Breast cancer is a very common disease that affects approximately 1 in 10 women at some point in their lives. Importantly, breast cancer cannot be considered a single disease as it is characterized by distinct pathological and molecular subtypes that are treated with different therapies and have diverse clinical outcomes. Although some highly successful treatments have been developed, certain b...
متن کاملBreast cancer imaging: a new role of Tc-99m sestamibi prone scintimammography for diagnosisof breast cancer
Mammography remians the procedure of choice in screening asymptomatic women for breast cancer. However, in patients with symptoms, other types of imaging play an important role in the detection of malignancies. The high cost and lack of availability of PET and MRI largely precludes the use in this patient population. TI-201 is nbt the imaging agent of choice because of its wash-out and redistri...
متن کاملNew Hope for Retinoblastoma Patients
Systemic chemotherapy regimens and focal treatment modalities such as radioactive plaque therapy have dramatically improved the outcomes of treatment for retinoblastoma such that patient survival with modern monitoring and treatment now exceeds 95%. Although the vast majority of patients respond adequately to current therapeutic strategies, treatment for a subset of patients with advanced retin...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JNCI Journal of the National Cancer Institute
سال: 2014
ISSN: 0027-8874,1460-2105
DOI: 10.1093/jnci/dju308